EBV Early Antigens Antibody (1108-1)
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-34333
![Novus Antibodies Novus Antibodies](https://resources.rndsystems.com/categoryimages/novus_antibodies.jpg)
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Virus
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # 1108-1
Concentration
0.2 mg/ml
Product Specifications
Immunogen
Affinity Purified early antigen polypeptides from induced Raji cells precipitated with African Burkitt's lymphoma sera
Reactivity Notes
EBV
Localization
Nuclear
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Description
200ug/ml of antibody purified from Bioreactor Concentrate by Protein A or G. Prepared in 10 mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0 mg/ml. (NBP2-34516)
Antibody with azide - store at 2 to 8C. Antibody without azide - store at -20 to -80C.
Antibody with azide - store at 2 to 8C. Antibody without azide - store at -20 to -80C.
Applications for EBV Early Antigens Antibody (1108-1)
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
1-2 ug/ml
Application Notes
Optimal dilution for a specific application should be determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
10 mM PBS with 0.05% BSA
Preservative
0.05% Sodium Azide
Concentration
0.2 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C.
Background: EBV Early Antigens
Alternate Names
Chronic ulcerative stomatitis protein, CUSP, Keratinocyte transcription factor KET, p40, p51, p63, p73L, TP63, Transformation-related protein 63, Tumor protein 63, Tumor protein p73-like
Additional EBV Early Antigens Products
Product Documents for EBV Early Antigens Antibody (1108-1)
Product Specific Notices for EBV Early Antigens Antibody (1108-1)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...